STAT March 20, 2020
Rebecca Robbins

A highly anticipated heart study of the Apple Watch is facing disruptions as a result of the coronavirus pandemic, with enrollment slowing down and both retail store restrictions and social distancing measures interfering with a novel plan for seniors to obtain the devices.

But, as the pandemic stretches on, the study could also become a test case for the opportunities of clinical research conducted remotely — both during the crisis and after it has passed.

The Heartline Study, being conducted jointly by Apple and Johnson & Johnson, aims to follow seniors — some of whom may have an undetected heart problem known as atrial fibrillation — to see what happens when they wear an Apple Watch or receive health tips...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Patient / Consumer, Pharma, Provider, Technology, Wearables
Low-cost wearable sensors may lead to better Parkinson’s care
Fitness trackers and phones can help monitor multiple sclerosis
Digital Phenotyping: emerging HealthTech sub sector is 'one to watch in 2024 and 2025'
Apple Watch’s ‘Foggy’ gets FDA medical device listing for Parkinson’s
At-Home Patients and AI: Q&A with Riccardo Butta

Share This Article